Brain repair for Parkinson's disease: is the answer in the matrix?
|dc.identifier.citation||Moriarty, Niamh, & Dowd, Eilís. (2018). Brain repair for Parkinson’s disease: is the answer in the matrix? Neural Regeneration Research, 13(7), 1187-1188. doi: 10.4103/1673-5374.235027||en_IE|
|dc.description.abstract||Two hundred years after James Parkinson first described the cardinal motor symptoms of the disorder that would later bear his name, there is still an irrefutable need for a therapy that targets the underlying pathophysiology of the disease and not solely its symptoms. Parkinson’s disease (PD) is classically characterised by Lewy body formation and a relatively selective degeneration of nigrostriatal dopaminergic neurons (Schapira and Jenner, 2011). The loss of dopaminergic neurons from the substantia nigra pars compacta causes a consequential depletion of the neurotransmitter dopamine from the striatum, and it is this loss that causes the motor symptoms experienced by patients. To date, all treatments for this condition are symptomatic in that they simply endeavour to correct the neurochemical and/or electrical anomalies caused by striatal dopaminergic deafferentation in an attempt to improve motor function (LeWitt and Fahn, 2016). While such symptomatic approaches show extraordinary efficacy in the early years after initiating treatment, the underlying disease pathology continues to progress, and eventually their efficacy subsides. In view of this, there remains an urgent need for an alternative treatment approach that is capable of protecting or repairing the brain in order to provide a more sustained benefit to patients.||en_IE|
|dc.description.sponsorship||Our research in this field is supported by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2015) under the Marie Sklodowska-Curie Innovative Training Networks and Grant Agreement No. 676408, Science Foundation Ireland (11/RFP/NES/3183), and through a postgraduate scholarship from the Irish Research Council to Niamh Moriarty.||en_IE|
|dc.relation.ispartof||Neural Regeneration Research||en|
|dc.title||Brain repair for Parkinson's disease: is the answer in the matrix?||en_IE|
|dc.contributor.funder||Science Foundation Ireland||en_IE|
|dc.local.contact||Eilís Dowd, Dept Of Pharmacology, Nui, Galway.. 2776 Email: email@example.com|
|dcterms.project||info:eu-repo/grantAgreement/EC/H2020::MSCA-ITN-ETN/676408/EU/Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach/BrainMatTrain||en_IE|
|dcterms.project||info:eu-repo/grantAgreement/SFI/SFI Research Frontiers Programme (RFP)/11/RFP.1/NES/3183/IE/Harnessing Adult Stem Cells for Neurotrophin Delivery to the Degenerating Brain/||en_IE|
Files in this item
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.
The following license files are associated with this item: